| Literature DB >> 24575302 |
Neasa Hogan1, Maria Kehoe1, Aidan Larkin2, Susan Coote1.
Abstract
Background. Mobility limitations are a key feature of MS and 25% will require the use of a walking aid 15 years after diagnosis. Few studies have specifically evaluated the effectiveness of physiotherapy and exercise interventions delivered in the community for those with significant disability. Methods. An assessor blind, block randomised, and controlled study recruited participants who required bilateral assistance for gait and who occasionally used wheelchairs for longer distances. They were randomised to 10 weeks of group physiotherapy (balance and strengthening exercises), individual physiotherapy, yoga group, or a control group. Results. Repeated measures ANOVA found significant time effects for physical component of MSIS-29v2 (f = 7.993, P = 0.006) and MFIS (f = 8.695, P = 0.004). The group × time interaction was significant for the BBS (f = 4.391, P = 0.006). Post hoc analysis revealed no difference between group and individual physiotherapy for BBS. There was no significant difference between groups but the 6MWT improved for individual physiotherapy (P = 0.001) and MSIS-29v2 psychological score for group physiotherapy (P = 0.005). Discussion. This study found that balance and strengthening exercises, delivered in the community to those with significant mobility limitations, improve balance. The effect on walking endurance and patient-reported outcomes are unclear and warrants further investigation with a larger control group with similar baseline characteristics to the intervention groups.Entities:
Year: 2014 PMID: 24575302 PMCID: PMC3910069 DOI: 10.1155/2014/109142
Source DB: PubMed Journal: Mult Scler Int ISSN: 2090-2654
Group physiotherapy exercises and their progressions.
|
|
Figure 1Flow of participants through the trial.
Baseline comparisons between groups.
| Group physiotherapy | Individual physiotherapy | Yoga | Control |
| |
|---|---|---|---|---|---|
| Age in years (SIQR) | 57 (10) | 52 (11) | 58 (8) | 49 (6) | 0.029b |
| Gender | |||||
| Male/female ( | 18/30 | 15/20 | 5/8 | 2/13 | 0.247c |
| GNDS mobility section score | |||||
| 3 (%) | 28 (58) | 21 (60) | 9 (69) | 5 (33.3) | 0.256c |
| 4 (%) | 17 (35) | 13 (37) | 4 (30) | 10 (66.7) | |
| Type of MS | |||||
| RRMS ( | 13 | 7 | 4 | 5 | 0.152c
|
| SPMS ( | 20 | 16 | 5 | 5 | |
| PPMS ( | 8 | 11 | 2 | 5 | |
| Unknown ( | 7 | 1 | 2 | 0 | |
| Time since diagnosis (years) | 18 (9) | 13 (8) | 15 (8) | 10 (3) | 0.002a |
| Time since onset of symptoms (years) | 22 (11) | 20 (13) | 21 (14) | 15 (7) | 0.233a |
| MSIS-29v2 physical component | 50.5 (±9) | 53.9 (±11.3) | 48 (±10) | 55 (±9) | 0.107a |
| MSIS-29v2 psychological component | 18 (5.5) | 18 (5) | 15 (3) | 16.5 (3.25) | 0.293 |
| MFIS | 40.7 (±16) | 46.7 (±14) |
| 47 (±15) |
|
| BBS | 28.5 (±9) | 30 (±11.5) | 22 (±13) | 18 (±6) | 0.391a |
| 6MWT (m) | 105.5 (56) | 89 (63) | 66 (57) | 79 (49) | 0.103a |
SIQR: semi-interquartile range, GNDS: Guys Neurological Disability Scale, RR: relapsing remitting, SP: secondary progressive, PP: primary progressive, MSIS: multiple sclerosis impact scale, MFIS: modified fatigue impact scale, BBS: berg balance scale, 6MWT: six-minute walk test, a = one way ANOVA, b = Kruskal Wallis test, c = Chi Squared test.
Descriptive statistics for study outcome measures.
| Group physiotherapy | Individual physiotherapy | Yoga | Control | |
|---|---|---|---|---|
| MSIS-29v2 physical component | ||||
| Premean (SD) | 50.5 (9.5) | 54 (11.5) | 48.3 (10.5) | 55.3(9.5) |
| Postmean (SD) | 45.9 (10.5) | 49.4 (12) | 49.6 (11.6) | 50.5 (11.3) |
| Mean Difference | −4.54 | −4.52 | 1.3 | −4.8 |
| (95% CI) | (−7.5, −1.5) | (−7.9, −1.1) | (−4.7, 7.3) | (−10.4, −0.6) |
|
| 0.004* | 0.012* | 0.645 | 0.08 |
| MSIS-29v2 psychological component | ||||
| Premedian (SIQR) | 18 (5.5) | 18 (5.38) | 14 (2.2) | 17 (4) |
| Postmedian (SIQR) | 15 (5.7) | 17 (4.8) | 15 (4) | 15 (4.5) |
| Median difference | −3 | −1 | 1 | 2 |
|
| 0.005* | 0.057 | 0.281 | 0.507 |
| MFIS (total score) | ||||
| Premean (SD) | 40.7 (16.2) | 46.6 (14.8) | 30.4 (17.1) | 49 (15.5) |
| Postmean (SD) | 35.6 (15.6) | 39.5 (13.7) | 32.5 (19.5) | 42.6 (17.1) |
| Mean difference | −5.1 | −7.4 | 2.15 | −6.4 |
| (95% CI) | ( −9.1, −1.2) | (−11.6, −3.2) | (−2.9, 7.2) | (−13.1, 0.4) |
|
| 0.011* | 0.001* | 0.374 | 0.062 |
| BBS | ||||
| Premean (SD) | 28.8 (9.5) | 30.4 (11.6) | 22.6 (12.6) | 24.9 (11.6) |
| Postmean (SD) | 34.5 (9.8) | 34.2 (9.8) | 27.9 (11.5) | 21.8 (11.9) |
| Mean difference | 5.7 | 3.7 | 5.3 | −3.1 |
| (95% CI) | (−3.6, 7.8) | (−1, 6.3) | (−3.1, 7.5) | (−2.8, 9.0) |
|
| <0.0001* | 0.008* | <0.0001* | 0.258 |
| 6-minute walk test (m) | ||||
| Premedian (SIQR) | 101 (39.5) | 83.8 (39.8) | 70 (30) | 83.5 (44) |
| Postmedian (SIQR) | 121.2 (47.4) | 100 (55) | 45 (54.5) | 90 (35) |
| Median difference | 20.2 | 16.2 | −25 | 6.5 |
|
| 0.08 | 0.002* | 0.553 | 0.363 |
SD: standard deviation, SIQR: semi-interquartile range, MSIS: multiple sclerosis impact scale, MFIS: modified fatigue impact scale, BBS: berg balance scale, *statistically significant at α = 0.05, apaired samples t-test, bWilcoxon signed rank test.
Figure 2Main problems reported by participants.